4CPS-057 Dalbavancina and tedizolid: adequate alternatives for strains with reduced sensitivity to vancomycin, daptomycin or linezolid?

BACKGROUND: We ask if dalvabancina and tedizolid are good alternatives for strains with reduced sensitivity to vancomycin, daptomycin or linezolid. PURPOSE: To determine the most cost-effective treatment option for GRAM +microorganisms with reduced sensitivity to vancomycin, linezolid or daptomycin,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Navarro, M, Betancor, T, Tévar, E, Calzado, G, Suárez, M, Plasencia, I, Ramos, E, Gómez, E, Ferrer, A, Vera, M, Merino, J
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 4: Clinical pharmacy services
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535377/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.148
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars